Skip Navigation


Biostatistics Advance Access originally published online on August 28, 2006
Biostatistics 2007 8(2):438-452; doi:10.1093/biostatistics/kxl021
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
8/2/438    most recent
kxl021v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Healy, B.
Right arrow Articles by Degruttola, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Healy, B.
Right arrow Articles by Degruttola, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org.

Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses

Brian Healy*

Department of Biostatistics, Harvard University, 655 Huntington Avenue, Boston, MA 02115, USA bhealy{at}hsph.harvard.edu

Victor Degruttola

Department of Biostatistics, Harvard University, 655 Huntington Avenue, Boston, MA 02115, USA

* To whom correspondence should be addressed.

The simplicity and flexibility of Markov models make them appealing for investigations of the acquisition of HIV drug-resistance mutations, whose presence can define specific Markov states. Because the exact time of acquiring a mutation is not observed during clinical research studies on HIV infection, it is important that methods for fitting such models accommodate interval-censored transition times. Furthermore, many such studies include patients with extensive treatment experience prior to the onset of the studies. Therefore, the virus in these patients may have already acquired resistance mutations by study entry. Retrospective data regarding the time on treatment, which is often known or known with error, provide information about the acquisition rates before the start of a study. Finally, variability in the genetic sequences of circulating HIV creates uncertainty in the Markov states. This paper considers approaches to fitting Markov models to data with interval-censored transition times when the time origin and the Markov states are known with error. The methods were applied to AIDS Clinical Trial Group protocol 398, a randomized comparison of mono- versus dual-protease inhibitor use in heavily pretreated patients. We found that the estimated rates of acquiring certain classes of mutations depended on the presence of others, and that the precision of these estimates can be considerably improved by inclusion of retrospective data.

Keywords: Hidden Markov models; HIV; Interval censoring; Resistance mutations; Uncertain time origin

Received November 28, 2005; revised April 18, 2006; revised August 3, 2006; accepted for publication August 21, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.